Intuitive Surgical (ISRG) Stock Analysis

OW

ISRG Equity Research — OVERWEIGHT — June 2026

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

Awaiting market data

Peer rank

44p

Investment card · ISRG

The price history across the full one-year window reveals a clear topping-and-declining pattern:

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Unambiguous downtrend across all timeframes. ISRG is in a bear market (down ~26% from the Jun 2025 high), with price below both the 50- and 200-day SMAs — the most bearish possible moving-average alignment.
  • Momentum remains firmly negative. The RSI at 37 has failed to sustain a recovery above 45, and the MACD continues to deepen into negative territory. No bullish momentum divergence is evident.
  • The $394–$397 zone is the only near-term support. The Bollinger lower band ($394.94) and the June 2 intraday low ($396.68) form a narrow support band. A close below $394 would likely accelerate selling toward the $380–$385 area.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

ISRG Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

27 min read

WebserviceX · Agentic Research Desk

ISRG Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T08:03:11Z · Maintained by Walter Vijayakumar · Methodology · Track record

ISRG Stock Rating Summary

ISRG bias

OVERWEIGHT

Horizon

Long-term

ISRG key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

ISRG catalyst watch

Unambiguous downtrend across all timeframes. ISRG is in a bear market (down ~26% from the Jun 2025 high), with price below both the 50- and 200-day SMAs — the most bearish possible moving-average alignment.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

Awaiting market dataPeer 44p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:16.788068+00:00.

5D move

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

-0.62%

Vol (20D ann.)

+27.15%

vs SPY: +0.02%

Close 399.69 (USD, vendor closes)

Batch scorecard · 2026-06-25 · ISRG

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace bff51082

No QC issues recorded.